Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amedisys Inc (NQ: AMED )

91.24 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 91.24
Bid (Size) 78.00 (1)
Ask (Size) 92.74 (1)
Prev. Close 91.24
Today's Range 91.24 - 91.24
52wk Range 73.10 - 96.44
Shares Outstanding 32,631,959
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Stocks To Turn $1,000 Into $10,000 in 10 Years
There are a few simple rules for investing for 10x returns but they are among the most difficult to follow. 
Via InvestorPlace
3 Stocks Profiting from America’s Long-Term Care Crisis
These long-term care stocks provide older Americans with the care they need and the income to pay for it well into retirement. 
Via InvestorPlace

Performance

YTD
-3.93%
-3.93%
1 Month
-1.00%
-1.00%
3 Month
-3.75%
-3.75%
6 Month
-1.05%
-1.05%
1 Year
+15.85%
+15.85%

More News

Read More
Cantor Fitzgerald Maintains Neutral Rating for Amedisys: Here's What You Need To Know
Via Benzinga
The 3 Best Stock Picks for This Week
Via InvestorPlace
Is NASDAQ:AMED suited for quality investing?
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
What 11 Analyst Ratings Have To Say About Amedisys
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
Analyst Ratings for Amedisys
Via Benzinga
Expert Ratings for Amedisys
Via Benzinga
Amedisys Inc. (NASDAQ: AMED) Near the Top of Equities by Percentage Gain on 6/5
Via Investor Brand Network
Why Shares of Amedisys Are Jumping Monday
Via The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
Is UnitedHealth Group Stock a Buy Now?
Via The Motley Fool
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
Via Benzinga
Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
Via Benzinga
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023
Via Benzinga
Optum's Decision To Target Amedisys Is Intriguing, Says Analyst
Via Benzinga
Why Shares Of Amedisys Inc Are Rising
Via Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.